查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2149703

個人化認知復健系統市場預測（2034 年）—按系統類型、技術、應用、護理環境、最終用戶、報銷模式和地區分類的全球分析

Personalized Cognitive Recovery Systems Market Forecasts to 2034 - Global Analysis By System Type, Technology, Application, Care Setting, End User, Reimbursement Model and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球個人化認知恢復系統市場預計到 2026 年將達到 7 億美元，並在預測期內以 14.7% 的複合年成長率成長，到 2034 年將達到 21 億美元。

個人化認知復健系統是由數位和硬體組成的專業生態系統，旨在促進患者在受傷或患病後進行有針對性的神經復健和認知功能恢復。這些系統利用自適應演算法、神經回饋機制和身臨其境型虛擬環境，提供個人化的治療性練習，從而刺激神經可塑性。它們包括行動應用程式、穿戴式感測器和基於雲端的分析平台，用於追蹤患者的復健進展並動態調整介入強度。使用這些系統可以確保患者獲得最佳的認知復健路徑，並提高其功能獨立性。

神經損傷發生率增加

隨著全球神經損傷和認知障礙發病率的上升，醫療機構被迫實施個人化的認知復健系統，以提供有針對性的復健方案。人們對神經可塑性和早期療育益處的認知不斷提高，正在加速將這些數位化工具整合到標準臨床框架中。人工智慧 (AI) 的進步為這一轉變提供了支持，提高了治療的準確性和適應性。因此，醫療機構正在投資建立專業的復健平台，以期在最大限度降低長期照護成本的同時，為患者實現最佳治療效果。

高昂的開發和實施成本

開發和實施先進的個人化認知復健系統成本高昂，是其商業性化應用的主要障礙。建構高度精準且科學嚴謹的治療流程通常需要複雜的縱向研究和先進的神經科學研究，這顯著增加了整體開發成本。此外，個體認知反應的差異性也限制了通用數位介入措施的可預測性。這些因素共同阻礙了市場擴張，尤其對於那些尋求實證、經濟有效的復健解決方案的醫療機構而言更是如此。

遠端醫療和遠距復健的擴展

遠端保健和遠距復健領域為個人化認知復健系統製造商提供了巨大的成長機遇，這主要得益於人們對便捷、持續照護日益成長的需求。以雲端應用為主要輸入方式的數位化平台，提供了一種擺脫臨床限制、高效能進行認知治療的途徑。隨著全球對數位醫療基礎設施投資的不斷成長，以及監管機構對遠距醫療路徑的鼓勵，我們預計先進復健解決方案的普及率將大幅提升，從而創造盈利的商業機會。

與傳統復健方法的競爭

對傳統面對面復健方法的持續依賴對個人化認知復健系統市場構成重大威脅。傳統的面對面治療和既定的介入框架通常具有較高的監管清晰度，並且在廣泛的臨床應用中具有成本效益。此外，標準化治療手冊的快速發展也提高了傳統介入方法的可信度。這種競爭壓力可能會阻礙市場滲透，尤其是在臨床療效檢驗和保險報銷是關鍵營運考量的情況下。

新型冠狀病毒（COVID-19）的影響：

疫情初期，由於醫療機構關閉和診斷調查延誤，臨床復健服務受到衝擊。然而，隨後遠端醫療的激增加速了數位化認知平台在居家治療的應用。疫情後，人們對便捷的神經系統疾病診療與數位醫療相結合的關注，促使對復健技術的長期投資不斷增加，推動了全球各臨床領域的市場強勁復甦和擴張。

預計在預測期內，數位療法（DTx）軟體領域將佔據最大佔有率。

由於其無與倫比的易用性和在各個臨床領域的廣泛適用性，預計數位療法 (DTx) 軟體領域將在預測期內佔據最大的市場佔有率。這些平台具有卓越的治療擴充性，即使在遠距環境下也能有效運行，從而顯著縮短評估等待時間，並最大限度地減少醫療服務提供的地域障礙。隨著醫療機構越來越重視高效且經濟的篩檢方法，對專業軟體工具的需求持續激增，鞏固了該領域在市場中的主導地位。

在預測期內，經顱直流電刺激（tDCS）領域預計將呈現最高的複合年成長率。

在預測期內，經顱直流電刺激 (tDCS) 領域預計將呈現最高的成長率，這主要得益於預測分析和行為模式識別技術的快速發展。這些技術能夠對複雜的認知數據進行精確分析，從而產生高度專業化且可靠的診斷結果，並可針對特定的神經系統疾病應用進行客製化。人工智慧 (AI) 的出現顯著提高了篩檢的準確性、擴充性和早期療育計畫的製定，從而顯著提升了該技術的經濟效益。因此，對數位健康調查投入的增加以及有利的臨床趨勢正在加速其在全球範圍內的商業化應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於該地區成熟的數位健康和​​診斷產業，該產業廣泛應用個人化認知復健系統。該地區受益於大量的研發投入、健全的智慧財產權保護以及政府對早期認知干預和數位療法的支持。此外，

透過合作，美國和加拿大進一步鞏固了該地區在全球市場的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體醫療保健的快速現代化以及兒童醫療保健行業的擴張。中國、印度和日本等國家正加大對數位醫療基礎設施和智慧醫療設備製造技術的投資，以滿足不斷成長的國內需求以及人們對神經認知障礙日益增強的認知。此外，有利的政府政策、不斷成長的醫療保健支出以及經濟高效的軟體開發資源的可用性，正在加速全部區域診斷工具的普及應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶的興趣，我們將提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球個人化認知恢復系統市場：依系統類型分類

  • 數位療法 (DTx) 軟體
  • 非侵入性神經刺激設備
  • 認知復健軟體套件
  • 多感官恢復環境
  • 人工智慧驅動的個人化復健計劃器

第6章：全球個人化認知恢復系統市場：依技術分類

  • 經顱直流電刺激（tDCS）
  • 利用機器學習進行進度追蹤與調整
  • 利用虛擬實境（VR）身臨其境型復健
  • 腦電生物回饋療法與神經調控
  • 數位表現型分析和被動資料收集

第7章 全球個人化認知恢復系統市場：依應用分類

  • 腦外傷（TBI）後的康復
  • 中風後的認知復健
  • 術後認知功能下降的管理
  • 長期新冠肺炎認知症狀的恢復
  • 化療引起的認知障礙（「化療腦」）

第8章：全球個人化認知復健系統市場：依護理環境分類

  • 住院復健機構
  • 門診診所和治療中心
  • 家庭和遠端恢復
  • 遠端醫療和虛擬護理平台
  • 長期照護機構及輔助住宅

第9章：全球個人化認知恢復系統市場：依最終用戶分類

  • 神經科醫生和復健科醫生
  • 物理治療師、職能治療師、語言治療師
  • 患者及其看護者
  • 健康保險提供者和保險支付方
  • 美國退伍軍人事務部（VA）和軍事醫院
  • 其他最終用戶

第10章 全球個人化認知恢復系統市場：依報銷模式分類

  • 保險範圍（CPT 代碼）
  • 消費者自費購買
  • 雇主提供的健康和福利計劃
  • 政府和退伍軍人事務部 (VA) 資助的項目

第11章 全球個人化認知恢復系統市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • MindMaze
  • Akili Interactive
  • Constant Therapy（Linus Health）
  • Posit Science（BrainHQ）
  • Neuroelectrics
  • Halo Neuroscience
  • Flow Neuroscience
  • Synchron
  • Kernel
  • CogniFit
  • BrainCo, Inc.
  • Mendi
  • LIFT Neuroscience
  • InteraXon（Muse）
  • Jabberbaby
  • Amira Learning
  • Starfish Therapies
  • Kaiko Health
Product Code: SMRC40135

According to Stratistics MRC, the Global Personalized Cognitive Recovery Systems Market is accounted for $0.7 billion in 2026 and is expected to reach $2.1 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Personalized cognitive recovery systems are specialized digital and hardware ecosystems designed to facilitate targeted neurological rehabilitation and cognitive function restoration following injury or illness. They function by utilizing adaptive algorithms, neurofeedback mechanisms, and immersive virtual environments to deliver personalized therapeutic exercises that stimulate neuroplasticity. These systems encompass mobile applications, wearable sensors, and cloud-based analytics platforms that track patient progress and adjust intervention intensity dynamically. Their application ensures optimized cognitive recovery trajectories and enhanced functional independence for patients undergoing rehabilitation.

Market Dynamics:

Driver:

Rising Incidence of Neurological Injuries

The rising global incidence of neurological injuries and cognitive disorders compels healthcare providers to adopt personalized cognitive recovery systems offering targeted rehabilitation alternatives. Growing recognition of neuroplasticity and early intervention benefits is accelerating the integration of these digital tools into standard clinical frameworks. This transition is supported by advancements in artificial intelligence, which enhance therapeutic precision and adaptability. Consequently, institutions are investing in specialized recovery platforms to achieve optimal patient outcomes while minimizing long-term care costs.

Restraint:

High Development and Integration Costs

The substantial expenses associated with developing and deploying advanced personalized cognitive recovery systems represent a significant barrier to widespread commercial adoption. Creating highly accurate and scientifically robust therapeutic algorithms often requires complex longitudinal studies and sophisticated neuroscientific research, which escalate overall production costs. Furthermore, the variability in individual cognitive responses limits the operational predictability of generalized digital interventions. These factors collectively constrain market expansion, particularly for healthcare providers seeking evidence-based, cost-effective rehabilitation solutions.

Opportunity:

Expansion in Telehealth and Remote Rehabilitation

The telehealth and remote rehabilitation sector presents substantial growth opportunities for personalized cognitive recovery system manufacturers due to increasing demand for accessible continuous care. Digital platforms offer a highly effective pathway to deliver cognitive therapy without clinical constraints, utilizing cloud-based applications as primary inputs. As global investments in digital health infrastructure expand and regulatory agencies favor remote care pathways, the adoption of advanced recovery solutions is expected to surge, creating lucrative enterprise avenues.

Threat:

Competition from Traditional Rehabilitation Methods

The continuous reliance on traditional in-person rehabilitation methodologies poses a considerable threat to the personalized cognitive recovery systems market. Conventional face-to-face therapy sessions and established manual intervention frameworks often exhibit superior regulatory clarity and can be more cost-effective for broad clinical adoption. Additionally, the rapid advancement of standardized therapeutic manuals is enhancing the reliability of conventional intervention methods. This competitive pressure may hinder market penetration, particularly where clinical validation and insurance reimbursement are primary operational considerations.

Covid-19 Impact:

The pandemic initially disrupted clinical rehabilitation services and delayed diagnostic research due to facility closures. However, the subsequent surge in remote healthcare accelerated the adoption of digital cognitive platforms for home-based therapy delivery. Post-pandemic, the heightened focus on accessible neurological care and digital health integration has reinforced long-term investments in recovery technologies, driving robust market recovery and expansion across diverse clinical sectors globally.

The digital therapeutics (DTx) Software segment is expected to be the largest during the forecast period

The digital therapeutics (DTx) Software segment is expected to account for the largest market share during the forecast period, due to its unparalleled accessibility and widespread applicability across diverse clinical sectors. These platforms offer exceptional therapeutic scalability and operate effectively in remote environments, which significantly reduces assessment wait times and minimizes geographical barriers in healthcare delivery. As institutions increasingly prioritize efficient and cost-effective screening methods, the demand for specialized software-based tools continues to surge, thereby solidifying their dominant market position.

The transcranial direct current stimulation (tDCS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the transcranial direct current stimulation (tDCS) segment is predicted to witness the highest growth rate, driven by rapid advancements in predictive analytics and behavioral pattern recognition. These technologies enable the precise analysis of complex cognitive data to produce highly specialized and robust diagnostic outputs tailored for specific neurological applications. The ability to enhance screening accuracy, scalability, and early intervention planning through AI significantly improves process economics. Consequently, increasing investments in digital health research and favorable clinical trends are accelerating commercial adoption globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the presence of well-established digital health and diagnostic industries that heavily utilize personalized cognitive recovery systems. The region benefits from substantial research and development investments, robust intellectual property protection, and supportive government initiatives promoting early cognitive intervention and digital therapeutics. Furthermore, the early adoption of advanced screening technologies by key industry players in

the United States and Canada reinforces the region's dominant position in the global landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid healthcare modernization and expanding pediatric care sectors in emerging economies. Countries such as China, India, and Japan are increasingly investing in digital health infrastructure and smart medical device manufacturing technologies to meet growing domestic demand and rising awareness of neurocognitive conditions. Additionally, favorable government policies, rising healthcare expenditures, and the availability of cost-effective software development resources are collectively driving the accelerated adoption of diagnostic tools across the region.

Key players in the market

Some of the key players in Personalized Cognitive Recovery Systems Market include MindMaze, Akili Interactive, Constant Therapy (Linus Health), Posit Science (BrainHQ), Neuroelectrics, Halo Neuroscience, Flow Neuroscience, Synchron, Kernel, CogniFit, BrainCo, Inc., Mendi, LIFT Neuroscience, InteraXon (Muse), Jabberbaby, Amira Learning, Starfish Therapies, and Kaiko Health.

Key Developments:

In September 2026, MindMaze launched a next-generation cognitive recovery platform optimized for elderly tracking, achieving a thirty percent improvement in neural processing speed while significantly reducing user interface complexity requirements for global healthcare providers.

In August 2026, Akili Interactive expanded its personalized algorithm capacity through a strategic partnership with a leading neuroscientific firm, enabling the scalable deployment of novel focus enhancement modules for corporate executive wellness programs.

In July 2026, Constant Therapy (Linus Health) secured a major supply agreement to provide customized cognitive assessment tools for a prominent senior living network, facilitating the efficient integration of digital biomarker tracking into next-generation aging-in-place ecosystems globally.

System Types Covered:

  • Digital Therapeutics (DTx) Software
  • Non-Invasive Neurostimulation Devices
  • Cognitive Rehabilitation Software Suites
  • Multisensory Recovery Environments
  • AI-Powered Personalized Recovery Planners

Technologies Covered:

  • Transcranial Direct Current Stimulation (tDCS)
  • Machine Learning Progress Tracking and Adaptation
  • Virtual Reality (VR) Immersive Rehabilitation
  • EEG Biofeedback and Neuromodulation
  • Digital Phenotyping and Passive Data Collection

Applications Covered:

  • Traumatic Brain Injury (TBI) Recovery
  • Post-Stroke Cognitive Rehabilitation
  • Post-Operative Cognitive Decline Management
  • Long-COVID Cognitive Symptom Recovery
  • Chemotherapy-Induced Cognitive Impairment ("Chemo Brain")

Care Settings Covered:

  • Inpatient Rehabilitation Facilities
  • Outpatient Clinics and Therapy Centers
  • Home-Based and Remote Recovery
  • Telehealth and Virtual Care Platforms
  • Long-Term Care and Assisted Living Facilities

End Users Covered:

  • Neurologists and Rehabilitation Physicians
  • Physical, Occupational, and Speech Therapists
  • Patients and Family Caregivers
  • Health Insurance Providers and Payers
  • Veteran Affairs (VA) and Military Hospitals
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Cognitive Recovery Systems Market, By System Type

  • 5.1 Digital Therapeutics (DTx) Software
  • 5.2 Non-Invasive Neurostimulation Devices
  • 5.3 Cognitive Rehabilitation Software Suites
  • 5.4 Multisensory Recovery Environments
  • 5.5 AI-Powered Personalized Recovery Planners

6 Global Personalized Cognitive Recovery Systems Market, By Technology

  • 6.1 Transcranial Direct Current Stimulation (tDCS)
  • 6.2 Machine Learning Progress Tracking and Adaptation
  • 6.3 Virtual Reality (VR) Immersive Rehabilitation
  • 6.4 EEG Biofeedback and Neuromodulation
  • 6.5 Digital Phenotyping and Passive Data Collection

7 Global Personalized Cognitive Recovery Systems Market, By Application

  • 7.1 Traumatic Brain Injury (TBI) Recovery
  • 7.2 Post-Stroke Cognitive Rehabilitation
  • 7.3 Post-Operative Cognitive Decline Management
  • 7.4 Long-COVID Cognitive Symptom Recovery
  • 7.5 Chemotherapy-Induced Cognitive Impairment ("Chemo Brain")

8 Global Personalized Cognitive Recovery Systems Market, By Care Setting

  • 8.1 Inpatient Rehabilitation Facilities
  • 8.2 Outpatient Clinics and Therapy Centers
  • 8.3 Home-Based and Remote Recovery
  • 8.4 Telehealth and Virtual Care Platforms
  • 8.5 Long-Term Care and Assisted Living Facilities

9 Global Personalized Cognitive Recovery Systems Market, By End User

  • 9.1 Neurologists and Rehabilitation Physicians
  • 9.2 Physical, Occupational, and Speech Therapists
  • 9.3 Patients and Family Caregivers
  • 9.4 Health Insurance Providers and Payers
  • 9.5 Veteran Affairs (VA) and Military Hospitals
  • 9.6 Other End Users

10 Global Personalized Cognitive Recovery Systems Market, By Reimbursement Model

  • 10.1 Insurance Reimbursed (CPT Codes)
  • 10.2 Out-of-Pocket Consumer Purchase
  • 10.3 Employer-Sponsored Health and Wellness Plans
  • 10.4 Government and VA Funded Programs

11 Global Personalized Cognitive Recovery Systems Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 MindMaze
  • 14.2 Akili Interactive
  • 14.3 Constant Therapy (Linus Health)
  • 14.4 Posit Science (BrainHQ)
  • 14.5 Neuroelectrics
  • 14.6 Halo Neuroscience
  • 14.7 Flow Neuroscience
  • 14.8 Synchron
  • 14.9 Kernel
  • 14.10 CogniFit
  • 14.11 BrainCo, Inc.
  • 14.12 Mendi
  • 14.13 LIFT Neuroscience
  • 14.14 InteraXon (Muse)
  • 14.15 Jabberbaby
  • 14.16 Amira Learning
  • 14.17 Starfish Therapies
  • 14.18 Kaiko Health

List of Tables

  • Table 1 Global Personalized Cognitive Recovery Systems Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Personalized Cognitive Recovery Systems Market Outlook, By System Type (2023-2034) ($MN)
  • Table 3 Global Personalized Cognitive Recovery Systems Market Outlook, By Digital Therapeutics (DTx) Software (2023-2034) ($MN)
  • Table 4 Global Personalized Cognitive Recovery Systems Market Outlook, By Non-Invasive Neurostimulation Devices (2023-2034) ($MN)
  • Table 5 Global Personalized Cognitive Recovery Systems Market Outlook, By Cognitive Rehabilitation Software Suites (2023-2034) ($MN)
  • Table 6 Global Personalized Cognitive Recovery Systems Market Outlook, By Multisensory Recovery Environments (2023-2034) ($MN)
  • Table 7 Global Personalized Cognitive Recovery Systems Market Outlook, By AI-Powered Personalized Recovery Planners (2023-2034) ($MN)
  • Table 8 Global Personalized Cognitive Recovery Systems Market Outlook, By Technology (2023-2034) ($MN)
  • Table 9 Global Personalized Cognitive Recovery Systems Market Outlook, By Transcranial Direct Current Stimulation (tDCS) (2023-2034) ($MN)
  • Table 10 Global Personalized Cognitive Recovery Systems Market Outlook, By Machine Learning Progress Tracking and Adaptation (2023-2034) ($MN)
  • Table 11 Global Personalized Cognitive Recovery Systems Market Outlook, By Virtual Reality (VR) Immersive Rehabilitation (2023-2034) ($MN)
  • Table 12 Global Personalized Cognitive Recovery Systems Market Outlook, By EEG Biofeedback and Neuromodulation (2023-2034) ($MN)
  • Table 13 Global Personalized Cognitive Recovery Systems Market Outlook, By Digital Phenotyping and Passive Data Collection (2023-2034) ($MN)
  • Table 14 Global Personalized Cognitive Recovery Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Personalized Cognitive Recovery Systems Market Outlook, By Traumatic Brain Injury (TBI) Recovery (2023-2034) ($MN)
  • Table 16 Global Personalized Cognitive Recovery Systems Market Outlook, By Post-Stroke Cognitive Rehabilitation (2023-2034) ($MN)
  • Table 17 Global Personalized Cognitive Recovery Systems Market Outlook, By Post-Operative Cognitive Decline Management (2023-2034) ($MN)
  • Table 18 Global Personalized Cognitive Recovery Systems Market Outlook, By Long-COVID Cognitive Symptom Recovery (2023-2034) ($MN)
  • Table 19 Global Personalized Cognitive Recovery Systems Market Outlook, By Chemotherapy-Induced Cognitive Impairment ("Chemo Brain") (2023-2034) ($MN)
  • Table 20 Global Personalized Cognitive Recovery Systems Market Outlook, By Care Setting (2023-2034) ($MN)
  • Table 21 Global Personalized Cognitive Recovery Systems Market Outlook, By Inpatient Rehabilitation Facilities (2023-2034) ($MN)
  • Table 22 Global Personalized Cognitive Recovery Systems Market Outlook, By Outpatient Clinics and Therapy Centers (2023-2034) ($MN)
  • Table 23 Global Personalized Cognitive Recovery Systems Market Outlook, By Home-Based and Remote Recovery (2023-2034) ($MN)
  • Table 24 Global Personalized Cognitive Recovery Systems Market Outlook, By Telehealth and Virtual Care Platforms (2023-2034) ($MN)
  • Table 25 Global Personalized Cognitive Recovery Systems Market Outlook, By Long-Term Care and Assisted Living Facilities (2023-2034) ($MN)
  • Table 26 Global Personalized Cognitive Recovery Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Personalized Cognitive Recovery Systems Market Outlook, By Neurologists and Rehabilitation Physicians (2023-2034) ($MN)
  • Table 28 Global Personalized Cognitive Recovery Systems Market Outlook, By Physical, Occupational, and Speech Therapists (2023-2034) ($MN)
  • Table 29 Global Personalized Cognitive Recovery Systems Market Outlook, By Patients and Family Caregivers (2023-2034) ($MN)
  • Table 30 Global Personalized Cognitive Recovery Systems Market Outlook, By Health Insurance Providers and Payers (2023-2034) ($MN)
  • Table 31 Global Personalized Cognitive Recovery Systems Market Outlook, By Veteran Affairs (VA) and Military Hospitals (2023-2034) ($MN)
  • Table 32 Global Personalized Cognitive Recovery Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 33 Global Personalized Cognitive Recovery Systems Market Outlook, By Reimbursement Model (2023-2034) ($MN)
  • Table 34 Global Personalized Cognitive Recovery Systems Market Outlook, By Insurance Reimbursed (CPT Codes) (2023-2034) ($MN)
  • Table 35 Global Personalized Cognitive Recovery Systems Market Outlook, By Out-of-Pocket Consumer Purchase (2023-2034) ($MN)
  • Table 36 Global Personalized Cognitive Recovery Systems Market Outlook, By Employer-Sponsored Health and Wellness Plans (2023-2034) ($MN)
  • Table 37 Global Personalized Cognitive Recovery Systems Market Outlook, By Government and VA Funded Programs (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.